dengvaxia
sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - - rokotteet - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 ja 4. käyttö dengvaxia pitäisi olla virallisten suositusten mukaisesti.
vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - rokotteet - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 ja 5. 1 in product information document). käyttö tämä rokote tulee virallisten suositusten mukaisesti.
amaryl 1 mg tabletti
sanofi oy - glimepiride - tabletti - 1 mg - glimepiridi
amaryl 2 mg tabletti
sanofi oy - glimepiride - tabletti - 2 mg - glimepiridi
frisium 10 mg tabletti
sanofi oy - clobazam - tabletti - 10 mg - klobatsaami
klexane cum conservans 100 mg/ml injektioneste, liuos
sanofi oy - enoxaparin sodium - injektioneste, liuos - 100 mg/ml - enoksapariini
cardace 2.5 mg tabletti
sanofi oy - ramipril - tabletti - 2.5 mg - ramipriili
cardace 5 mg tabletti
sanofi oy - ramipril - tabletti - 5 mg - ramipriili
cardace comp 2,5 mg / 12,5 mg tabletti
sanofi oy - hydrochlorothiazide, ramipril - tabletti - 2,5 mg / 12,5 mg - ramipriili ja diureetit
cardace 10 mg tabletti
sanofi oy - ramipril - tabletti - 10 mg - ramipriili